Clinical Trial Update: Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intranasal cenegermin for efficacy and safety in adults with non-arteritic anterior ischemic optic neuropathy is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-arteritic Anterior Ischemic Optic Neuropathy

Drugs mentioned

• cenegermin (cenegermin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Non-Arteritic Anterior Ischemic Optic Neuropathy | Phase 3 | Status: NOT_YET_RECRUITING